Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Sees Large Growth in Short Interest

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 500 shares, a growth of 400.0% from the February 29th total of 100 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 0.1 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Shares of NASDAQ HROWM opened at $26.75 on Friday. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52-week low of $22.71 and a 52-week high of $27.72. The company’s 50 day moving average price is $26.04 and its 200-day moving average price is $25.68.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 31st. Shareholders of record on Monday, January 15th were issued a dividend of $0.7422 per share. This represents a $2.97 dividend on an annualized basis and a dividend yield of 11.10%. The ex-dividend date was Thursday, January 11th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.